期刊文献+

肿瘤特异性生长因子在子宫内膜癌的应用价值 被引量:6

Clinical value of TSGF in carcinoma of endometrium
下载PDF
导出
摘要 目的探讨血清TSGF检测对子宫内膜癌的应用价值。方法对37例子宫内膜癌患者术前外周血及术中子宫静脉血中TSGF进行检测,并与CA125、cy21-1比较。结果子宫内膜癌患者血清TSGF含量及阳性率明显升高,敏感性为64.9%,特异性为62.5%;与术前外周血相比,术中子宫静脉血TSGF含量明显升高(P<0.05),阳性率略有上升;随着病理分级及临床期别的升高,血清TSGF含量呈上升的趋势;TSGF和CA125联合检测,敏感性可由单项TSGF的64.9%、CA125的29.7%提高到75.7%,特异性没有明显下降。结论血清TSGF检测对子宫内膜癌具有一定的诊断价值,癌旁静脉血TSGF升高更为明显,并与病理分级及临床期别有一定关系,TSGF+CA125联合检测具有更高的诊断价值。 [Objective] To estimate the clinical value of tumor specific growth factor (TSGF) in the diagnosis and monitoring of Carcinoma of Endometrium. [Methods] We collected the peripheral veins and uterine veins of the patients of Carcinoma of Endometrium, and examined the level of TSGF, then compared with CA125 and cy21-1.[Results] The level and the positive rate of TSGF for Carcinoma of Endometrium was significantly higher than other group (P 〈0.05). The sensitivity and specificity were 64.9% and 62.5% resepectivily. Compared with the peripheral veins, the level of TSGF in the uterine veins was much higher (P 〈0.05), and the positive rate increased appreciably.The serum level of TSGF correlated with histologic grades and the stages. The sensitivity of combining TSGF and CA125 was 75.7%, and it was better than TSGF or CA125 alone. [Conclusions] Serum TSGF level is helpful in diagnosis of Carcinoma of Endometrium, and is related with differentiation and clinical-stage. Combining TSGF and CA125 can improve the diagnostic sensitivity of Carcinoma of Endometrium.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第14期2199-2201,共3页 China Journal of Modern Medicine
基金 常州市级科研项目(NO:CS2004215)
关键词 子宫内膜癌 TSGF CA125 cy21-1 肿瘤标志物 carcinoma of endometrium tumor specific growth factor CA125 cy21-1 tumor marks
  • 相关文献

参考文献7

二级参考文献19

  • 1尹雪彬,沈铿,郎景和.子宫内膜癌的病理分类、治疗及预后影响因素的现代观[J].中华妇产科杂志,1996,31(8):508-511. 被引量:23
  • 2徐元斌 王德春 等.恶性肿瘤特异性生长因子(TSGF)测定及临床应用[J].福建医学检验,1996,1(3):118-118.
  • 3谷铣之.肿瘤放射生物学[M].北京:人民卫生出版社,1983.4.
  • 4钟刚.子宫内膜癌患者液体宫腔镜检查后的腹腔细胞学[J].国外医学:妇产科学分册,1998,5:315-315.
  • 5冯缵冲.实用宫腔镜学[M].上海:上海医科大学出版社,1992.87.
  • 6孟冬娅 薛文成.血管内皮细胞生长因子(VEGF)和肿瘤[J].中国特色医药杂志,2000,2(5):15-16.
  • 7Obermair A,Obstet Gynecol,1999年,93卷,3期,367页
  • 8陈忠年,妇产科病理学,1996年,149页
  • 9Folkman J,J Natl Cancer Ins,1990年,80卷,1期,4页
  • 10刘胜春,吴凯南,厉红元.血管生成在乳腺非典型增生及癌变过程中的作用[J].中国肿瘤临床,1998,25(6):421-424. 被引量:35

共引文献126

同被引文献38

  • 1王志启.醋酸甲地孕酮和他莫昔芬治疗晚期子宫内膜癌的II期试验——GOG的一项研究[J].国外医学(妇产科学分册),2004,31(6):390-391. 被引量:1
  • 2杨丹,韩立敏.1969-2003年子宫内膜癌发病率及发病因素分析[J].复旦学报(医学版),2005,32(4):479-480. 被引量:33
  • 3孙昕,秦利华,童辉.合肥地区健康体检人群中TSGF值的调查[J].中国肿瘤临床与康复,2005,12(6):497-498. 被引量:1
  • 4XU LZ.Tumor of Pragmatic Pathology Method[J].Shanghai:Publishing Company of Shanghai Medical University,1997:532.
  • 5UNDERWOOD JCE,GIRI DD.Nucleolar organizer regions as diagnostic discriminantsfor malignancy[J].J Pathol,1988,155(2):95-97.
  • 6SAH SP,DAWAR R,KUMAR L,et al.Nucleolar organizer regions as a prognostic indicator in epithelial cancers of the ovary[J].Iht J Gynecol Pathol,2004,23(4):347-353.
  • 7TERLIKOWSKI S,DZIECIOL J,MAZUREK A,et aL A morphometric study of nucleolar organiser regions in cervical intraepithelial neoplasia[J].Folia Morphol (Warsz),2004,63(2):209-212.
  • 8MISRA JS,DAS V,SRIVASTAVA AN,et al.AgNOR counts in cervical smears under normal and other cytopathologic conditions[J].Anal Quant Cytol Histol,2005,27(6):337-340.
  • 9BERNY W,WEISER A,MARKOWSKA,et al.Analysis of PCNA,Ki67,AgNOR and p53 expression in brain glial tumors[J].Neurol Neurochir Poi,2004,38(6):457-463.
  • 10KHANNA AK,YADAV SK,DIXIT VK,et al.AgNOR count and subjective AgNOR pattern assessment (SAPA) score in carcinoma of the pancreatic head including periampullary tumors[J].JOP,2005,6(6):575-580.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部